Having a higher level of cardiorespiratory fitness reduced the risk for cognitive decline and Alzheimer’s, even in people at ...

Stroke was the fourth leading cause of death in the U.S. in 2023, according to the Centers for Disease Control and Prevention ...

The pharmaceutical giant presented mid-stage trial data on the pill, muvalaplin, at the American Heart Association Scientific ...

Zerlasiran was found to be well tolerated and no significant safety concerns were observed. Credit: Good dreams - Studio via ...

Middle-aged adults with long-term fluctuations in blood pressure may face a higher risk for sudden cardiac death than their ...

Both the nasal and IV forms of bumetanide had a variability in absorption of 27%, suggesting a more stable route of dosing ...

Valuable data can successfully be collected with the noninvasive wearable, which is worn on the sternum, report investigators ...

Ablation is a minimally invasive procedure to treat abnormal electrical short circuits caused by a heart attack. These ...

The combination of sacubitril and valsartan reduces the cardiotoxicity related to anthracycline chemotherapy drugs, according ...

Treatment with the Type 2 diabetes medication metformin, lifestyle changes, or a combination of both did not improve atrial ...

Mark Laurrie, superintendent of Niagara Falls City School District, is working with the American Heart Association and 16 ...

The FDA rejected an application from Astellas seeking to change the prescribing label for its eye drug Izervay to allow less ...